Braveheart Bio, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy (NCT07755904) | Braveheart Bio, Inc. | 2026-10-01 |
Track Braveheart Bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.